Skip to main content
APRINOIA Therapeutics Inc. (APRI)
APRINOIA Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$10.00 - $14.00
Shares Offered
2,000,000
Deal Size
$24.00M

APRINOIA Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
-28.23-23.26
Depreciation & Amortization
0.440.32
Share-Based Compensation
1.910.91
Other Operating Activities
8.64-2.27
Operating Cash Flow
-17.24-24.3
Capital Expenditures
-2.02-0.5
Other Investing Activities
-0.18
Investing Cash Flow
-2.02-0.32
Share Issuance / Repurchase
931.67
Debt Issued / Paid
3.09-0.18
Other Financing Activities
-0.74-
Financing Cash Flow
11.3531.49
Net Cash Flow
-8.456.81
Free Cash Flow
-19.25-24.8
Free Cash Flow Margin
-4886.55%-4509.09%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).